Your browser doesn't support javascript.
loading
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).
Siva, Shankar; Ali, Muhammad; Correa, Rohann J M; Muacevic, Alexander; Ponsky, Lee; Ellis, Rodney J; Lo, Simon S; Onishi, Hiroshi; Swaminath, Anand; McLaughlin, Mark; Morgan, Scott C; Cury, Fabio L; Teh, Bin S; Mahadevan, Anand; Kaplan, Irving D; Chu, William; Grubb, William; Hannan, Raquibul; Staehler, Michael; Warner, Andrew; Louie, Alexander V.
Afiliação
  • Siva S; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: shankar.siva@petermac.org.
  • Ali M; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
  • Correa RJM; Department of Radiation Oncology, London Regional Cancer Program, London, ON, Canada.
  • Muacevic A; European Radiosurgery Center Munich, University of Munich Hospitals, Munich, Germany.
  • Ponsky L; Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Ellis RJ; GenesisCare USA, Fort Myers, FL, USA.
  • Lo SS; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
  • Onishi H; Department of Radiology, University of Yamanashi, Yamanashi, Japan.
  • Swaminath A; Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • McLaughlin M; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Morgan SC; Department of Radiology, Radiation Oncology and Medical Physics, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
  • Cury FL; Division of Radiation Oncology, Department of Oncology, McGill University Health Centre, Montreal, QC, Canada.
  • Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research Institute, Houston, TX, USA.
  • Mahadevan A; Department of Radiation Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
  • Kaplan ID; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Chu W; Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
  • Grubb W; Department of Radiation Oncology, Augusta University, Augusta, GA, USA.
  • Hannan R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Staehler M; Department of Urology, University of Munich Hospitals, Munich, Germany.
  • Warner A; Department of Radiation Oncology, London Regional Cancer Program, London, ON, Canada.
  • Louie AV; Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Lancet Oncol ; 23(12): 1508-1516, 2022 12.
Article em En | MEDLINE | ID: mdl-36400098
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células Renais / Carcinoma de Células de Transição / Radiocirurgia / Neoplasias Renais Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células Renais / Carcinoma de Células de Transição / Radiocirurgia / Neoplasias Renais Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article